Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Accuray Inc (NQ: ARAY )

5.190 USD UNCHANGED
Streaming Delayed Price Updated: 7:46 PM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.190
Bid (Size) 4.580 (5)
Ask (Size) 5.540 (11)
Prev. Close 5.190
Today's Range 5.190 - 5.190
52wk Range 1.330 - 5.420
Shares Outstanding 85,638,116
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Accuray Reports Second Quarter Fiscal 2021 Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2021 ended December 31, 2020. 
From PR Newswire
Seven-year Data Shows Accuray TomoTherapy® System Provides Excellent Long-Term Control of Low-Risk Breast Cancer
Advanced, 10-Day Radiation Treatment Regimen Enables Patients to Get Back to Their Life, Faster 
From PR Newswire

Performance

YTD
+22.12%
+22.12%
1 Month
+21.83%
+21.83%
3 Month
+82.75%
+82.75%
6 Month
+128.63%
+128.63%
1 Year
+37.67%
+37.67%

More News

Read More
Accuray to Report Second Quarter Fiscal 2021 Financial Results on January 27, 2021
From PR Newswire
Accuray To Participate at J.P. Morgan's 39th Annual Healthcare Conference
From PR Newswire
Accuray Receives 510(k) FDA Clearance for ClearRT™ Helical kVCT Imaging for the Radixact® Treatment Delivery System
From PR Newswire
Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
From PR Newswire
Accuray and DHL Supply Chain establish global service logistics platform to support delivery of advanced cancer treatment technology
From PR Newswire
Accuray Appoints Renowned Medical Device Industry Executive Jim Dennison as Senior Vice President of Global Quality and Regulatory Affairs
From PR Newswire
Accuray Showcases Radiation Therapy Innovations Designed to Enable Better Outcomes with Less Damage, Less Time, and Less Cost, at ASTRO 2020
From PR Newswire
Accuray Reports First Quarter Fiscal 2021 Financial Results
From PR Newswire
Accuray Announces Agreement with Brainlab to Expand CyberKnife® Platform Treatment Capabilities for the Neuro-Radiosurgery Market
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.